The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Cell cycle inhibitors in normal and tumor stem cells.
Abstract
Emerging data suggest that stem cells may be one of the key elements in normal tissue regeneration and cancer development, although they are not necessarily the same entity in both scenarios. As extensively demonstrated in the hematopoietic system, stem cell repopulation is hierarchically organized and is intrinsically limited by the intracellular cell cycle inhibitors. Their inhibitory effects appear to be highly associated with the differentiation stage in stem/progenitor pools. While this negative regulation is important for maintaining homeostasis, especially at the stem cell level under physiological cues or pathological insults, it constrains the therapeutic use of adult stem cells in vitro and restricts endogenous tissue repair after injury. On the other hand, disruption of cell cycle inhibition may contribute to the formation of the so-called 'tumor stem cells' (TSCs) that are currently hypothesized to be partially responsible for tumorigenesis and recurrence of cancer after conventional therapies. Therefore, understanding how cell cycle inhibitors control stem cells may offer new strategies not only for therapeutic manipulations of normal stem cells but also for novel therapies selectively targeting TSCs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The p16-Arf locus encodes 2 tumor suppressors, p16 and Arf.10-12”
From Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner (2014) · cites this paper as [12]
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
Doetsch, F., Caillé, I., Lim, D. A., García-Verdugo, J. M., & Alvarez-Buylla, A. (1999) · Cell · doi:10.1016/s0092-8674(00)80783-7 · Cited by 3,898
Osteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Pajevic, P. D., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,559
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,288
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
Checkpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,053
Flagged first, then by citations
Cited by
Sorted by citations
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
Gao, M.-Q., Choi, Y.-P., Kang, S., Youn, J. H., & Cho, N. H. (2010) · Oncogene · doi:10.1038/onc.2010.35 · Cited by 389
Liver stem cells and hepatocellular carcinoma†
Mishra, L., Banker, T. P., Murray, J. C., Byers, S. W., Thenappan, A., He, A. R., Shetty, K., Johnson, L. B., & Reddy, E. P. (2008) · Hepatology · doi:10.1002/hep.22704 · Cited by 339
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Viale, A., Franco, F., Orleth, A., Cambiaghi, V., Giuliani, V., Bossi, D., Ronchini, C., Ronzoni, S., Muradore, I., Monestiroli, S., et al. (2008) · Nature · doi:10.1038/nature07618 · Cited by 314
Retention of Intrinsic Stem Cell Hierarchies in Carcinoma-Derived Cell Lines
Locke, M., Heywood, M., Fawell, S. C., & Mackenzie, I. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0931 · Cited by 258
Wu, C. X., Wang, X. Q., Chok, K., Man, K., Tsang, S. H. Y., Chan, A. C. Y., Wing, K., Xia, W. G., & Cheung, T. T. (2018) · Theranostics · doi:10.7150/thno.25487 · Cited by 228
Tumour stem cell-targeted treatment: elimination or differentiation
Massard, C., Deutsch, É., & Soria, J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl074 · Cited by 184
Hair follicle stem cells: Walking the maze
Tiede, S., Kloepper, J. E., Bodó, E., Tiwari, S., Kruse, C., & Paus, R. (2007) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2007.03.006 · Cited by 178
Shao, L., Feng, W., Li, H., Gardner, D., Luo, Y., Wang, Y., Liu, L., Meng, A., Sharpless, N. E., & Zhou, D. (2014) · Blood · doi:10.1182/blood-2013-07-515619 · Cited by 165
microRNAs regulate human embryonic stem cell division
Qi, J., Yu, J., Shcherbata, H. R., Mathieu, J., Wang, A. J., Seal, S., Zhou, W., Stadler, B., Bourgin, D., Wang, L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10033 · Cited by 162
Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies
Sakariassen, P. Ø., Immervoll, H., & Chekenya, M. (2007) · Neoplasia · doi:10.1593/neo.07658 · Cited by 158
Lee, E., Wang, J., Yumoto, K., Jung, Y., Cackowski, F. C., Decker, A. M., Li, Y., Franceschi, R. T., Pienta, K. J., & Taichman, R. S. (2016) · Neoplasia · doi:10.1016/j.neo.2016.07.007 · Cited by 151
Hoi, C. S. L., Lee, S. E., Lu, S.-Y., McDermitt, D. J., Osorio, K. M., Piskun, C. M., Peters, R. M., Paus, R., & Tumbar, T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01308-09 · Cited by 120
Peng, D., Wang, H., Li, L., Ma, X., Chen, Y., Zhou, H., Luo, Y., Xiao, Y., & Liu, L. (2018) · Leukemia · doi:10.1038/s41375-018-0015-2 · Cited by 115
Hu, L., Ru, K., Zhang, L., Huang, Y.-T., Zhu, X., Liu, H., Zetterberg, A., Cheng, T., & Miao, W. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-3 · Cited by 107
Self-citationMyeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3
Yoneda‐Kato, N., Tomoda, K., Umehara, M., Arata, Y., & Kato, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600656 · Cited by 103
Scl regulates the quiescence and the long-term competence of hematopoietic stem cells
Lacombe, J., Herblot, S., Rojas‐Sutterlin, S., Haman, A., Barakat, S., Iscove, N. N., Sauvageau, G., & Hoang, T. (2009) · Blood · doi:10.1182/blood-2009-01-201384 · Cited by 107
Sox2 Suppression by miR-21 Governs Human Mesenchymal Stem Cell Properties
Trohatou, O., Zagoura, D., Bitsika, V., Pappa, K. I., Antsaklis, A., Anagnou, N. P., & Roubelakis, M. G. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0081 · Cited by 85
Park, C., Kim, G., Kim, G., Choi, B. T., Park, Y., & Choi, Y. H. (2006) · Oncology Reports · doi:10.3892/or.15.5.1225 · Cited by 83
Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury.
Shao, L., Wang, Y., Chang, J., Luo, Y., Meng, A., & Zhou, D. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.07.03 · Cited by 87
A critical role for Apc in hematopoietic stem and progenitor cell survival
Qian, Z., Chen, L., Fernald, A. A., Williams, B. O., & Beau, M. M. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080578 · Cited by 81
The MicroRNA Pathway Plays a Regulatory Role in Stem Cell Division
Shcherbata, H. R., Hatfield, S. D., Ward, E. J., Reynolds, S., Fischer, K. A., & Ruohola‐Baker, H. (2006) · Cell Cycle · doi:10.4161/cc.5.2.2343 · Cited by 74
Cell cycle regulation of hematopoietic stem or progenitor cells
Hao, S., Chen, C., & Cheng, T. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-1984-4 · Cited by 76
Self-citationZheng, Z. S., Jia, J., Zhang, X., Zara, J. N., Yin, W., Chiang, M., Liu, Y., Wang, J., Pang, S., Ting, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.049 · Cited by 68
Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model
Hu, X., Shen, H., Tian, C., Yu, H. M., Zheng, G., XuFeng, R., Ju, Z., Xu, J., Wang, J., & Cheng, T. (2009) · Blood · doi:10.1182/blood-2009-06-227843 · Cited by 66
Self-citationNanotechnology in oncology: advances in biosynthesis, drug delivery, and theranostics
Ammar, M. M., Ali, R., Elaziz, N. A. A., Habib, H., Abbas, F. M., Yassin, M. T., Maniah, K., & Abdelaziz, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-02664-3 · Cited by 64
Tong, J., Sun, T., Ma, S., Zhao, Y., Ju, M., Gao, Y., Zhu, P., Tan, P., Fu, R., Zhang, A., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.018 · Cited by 68
Self-citationWolfe, A. R., Debeb, B. G., Lacerda, L., Larson, R. A., Bambhroliya, A. B., Huang, X., Bertucci, F., Finetti, P., Birnbaum, D., Laere, S. V., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3645-3 · Cited by 62
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer
Dunn, K. B., Heffler, M., & Golubovskaya, V. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728657 · Cited by 59
Qiu, J., Takagi, Y., Harada, J., Topalkara, K., Wang, Y., Sims, J. R., Zheng, G., Huang, P., Ling, Y., Scadden, D. T., et al. (2009) · Stem Cells · doi:10.1002/stem.1 · Cited by 59
Self-citationTabruyn, S. P., Nguyen, N.-Q.-N., Cornet, A. M., MARTIAL, J. A., & Struman, I. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0515 · Cited by 52
Gao, Y., Yang, P., Shen, H., Yu, H. M., Song, X., Zhang, L., Zhang, P., Cheng, H., Xie, Z., Hao, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7328 · Cited by 49
Self-citationThe SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs
Rodríguez, S., Wang, L., Mumaw, C. L., Srour, E. F., Celso, C. L., Nakayama, K. I., & Carlesso, N. (2011) · Blood · doi:10.1182/blood-2010-11-321521 · Cited by 48
Su, L. (2009) · Oncology Reports · doi:10.3892/or_00000599 · Cited by 46
Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3
Wang, Y., Gao, A., Zhao, H., Lu, P., Cheng, H., Dong, F., Gong, Y., Ma, S., Zheng, Y., Zhang, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.81 · Cited by 39
Self-citationBayati, S., Bashash, D., Ahmadian, S., Safaroghli‐Azar, A., Alimoghaddam, K., Ghavamzadeh, A., & Ghaffari, S. H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.006 · Cited by 39
Wang, L., Huang, J., Jiang, M., & Sun, L. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23030 · Cited by 38
Kanatsu‐Shinohara, M., Takashima, S., & Shinohara, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914448107 · Cited by 38
Fu, H., Chuang, I., Yang, Y.-C., Chuang, P.-C., Lin, H., Ou, Y., Chien, C.-C. C., Huang, H., & Kang, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092541 · Cited by 35
DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis
Zhang, P., Xu, X., Hu, X., Wang, H., Fassett, J. T., Huo, Y., Chen, Y., & Bache, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079444 · Cited by 34
Bae, S.-J., & Choi, Y. H. (2006) · Phytotherapy Research · doi:10.1002/ptr.2020 · Cited by 34
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Jung, Y., Decker, A. M., Wang, J., Lee, E., Kana, L. A., Yumoto, K., Cackowski, F. C., Rhee, J., Carmeliet, P., Buttitta, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8365 · Cited by 34
DCAF1 controls T-cell function via p53-dependent and -independent mechanisms
Guo, Z., Kong, Q., Liu, C., Zhang, S., Zou, L., Yan, F., Whitmire, J. K., Xiong, Y., Chen, X., & Wan, Y. Y. (2016) · Nature Communications · doi:10.1038/ncomms10307 · Cited by 32
Han, X., Zhang, J., Peng, Y., Peng, M., Chen, X., Chen, H., Song, J., Hu, X., Ye, M., Li, J., et al. (2016) · Blood · doi:10.1182/blood-2016-09-739268 · Cited by 32
Zhou, Z.-H., Ping, Y., Yu, S., Liang, Y., Yao, X., Chen, J., Cui, Y., & Bian, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.033 · Cited by 31
Tian, C., Zheng, G., Cao, Z., Li, Q., Ju, Z., Wang, J., Yuan, W., & Cheng, T. (2013) · Cell Cycle · doi:10.4161/cc.23160 · Cited by 30
Self-citationExpansion of hematopoietic stem/progenitor cells
Wu, H., Xin‐Na, D., & Duan, H. (2008) · American Journal of Hematology · doi:10.1002/ajh.21262 · Cited by 30
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
Boyer, M. J., & Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303064 · Cited by 34
Self-citationMolecular and Cellular Basis of Regeneration and Tissue Repair
Pajalunga, D., Mazzola, A., Franchitto, A., Puggioni, E. M. R., & Crescenzi, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7425-z · Cited by 29
Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
Sabatel, C., Cornet, A. M., Tabruyn, S. P., Malvaux, L., Castermans, K., MARTIAL, J. A., & Struman, I. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-231 · Cited by 27
Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303066 · Cited by 26
Self-citationTrohatou, O., Zagoura, D., Orfanos, N. K., Pappa, K. I., Marinos, E., Anagnou, N. P., & Roubelakis, M. G. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0203 · Cited by 25
Fujita, M., Takeshita, H., & Sawa, H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000407 · Cited by 25
Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma
Avigad, S., Shukla, S., Naumov, I., Cohen, I. J., Ash, S., Meller, I., Kollender, Y., Issakov, J., & Yaniv, I. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22115 · Cited by 25
Mishra, C. B., Mongre, R. K., Kumari, S., Jeong, D. K., & Tiwari, M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01007 · Cited by 24
Implications of a simple mathematical model to cancer cell population dynamics
Garner, A. L., Lau, Y. Y., Jordan, D. W., Uhler, M. D., & Gilgenbach, R. M. (2006) · Cell Proliferation · doi:10.1111/j.1365-2184.2006.00368.x · Cited by 24
Cancerous stem cells: deviant stem cells with cancer-causing misbehavior
Chandler, J. M., & Lagasse, E. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt13 · Cited by 25
Yuan, Y., Yu, H. M., Boyer, M. J., Song, X., Cao, S., Shen, H., & Cheng, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2945 · Cited by 22
Self-citationRegulating Quiescence: New Insights into Hematopoietic Stem Cell Biology
Passegue, E. A., & Wagers, A. J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.002 · Cited by 21
Cul4A is required for hematopoietic stem-cell engraftment and self-renewal
Li, B., Jia, N., Waning, D. L., Yang, F., Haneline, L. S., & Chun, K. T. (2007) · Blood · doi:10.1182/blood-2006-12-064154 · Cited by 20
Pleiotropic p27Kip1, BCR-ABL and leukemic stem cell: the trio in concert
Sengupta, A., & Banerjee, S. (2007) · Leukemia · doi:10.1038/sj.leu.2404842 · Cited by 20
A molecular signaling map and its application
Li, J., & Mansmann, U. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.022 · Cited by 19
Sphere-induced reprogramming of RPE cells into dual-potential RPE stem-like cells
Chen, F., Liu, X., Chen, Y., Liu, J. Y., Lü, H., Wang, W., Lu, X., Dean, K. C., Gao, L., Kaplan, H. J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102618 · Cited by 19
Salim, K., Guest, P. C., Skynner, H. A., Bilsland, J., Bonnert, T. P., McAllister, G., & Muñoz-Sanjuán, I. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.00100 · Cited by 19
Tong, J., Sun, T., Ma, S., Zhao, Y., Ju, M., Gao, Y., Zhu, P., Tan, P., Fu, R., Zhang, A., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.026 · Cited by 18
Self-citationGlasstetter, L. M., Oderinde, T. S., Mirchandani, M., Rajagopalan, K. S., Barsom, S. H., Thaler, R., Siddiqi, S., Zhu, X., Tang, H. R., Jordan, K. L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03372-x · Cited by 17
Mechanisms of action of hESC-secreted proteins that enhance human and mouse myogenesis
Yousef, H., Conboy, M. J., Mamiya, H., Zeiderman, M., Schlesinger, C., Schaffer, D. V., & Conboy, I. M. (2014) · Aging · doi:10.18632/aging.100659 · Cited by 16
Early hematopoiesis inhibition under chronic radiation exposure in humans
Akleyev, А. V., Akushevich, I. V., Dimov, G. P., Veremeyeva, G. A., Varfolomeyeva, T. A., Ukraintseva, S. V., & YASHIN, A. I. (2010) · Radiation and Environmental Biophysics · doi:10.1007/s00411-010-0269-1 · Cited by 16
Long non‐coding RNA MRPL23‐AS1 suppresses anoikis in salivary adenoid cystic carcinoma in vitro
Li, Y., Fu, M., Song, Y., Li, H., & Ge, X. (2022) · Oral Diseases · doi:10.1111/odi.14156 · Cited by 15
Tomiatti, V., Istvánffy, R., Pietschmann, E., Kratzat, S., Hoellein, A., Quintanilla-Fend, L., von Bubnoff, N. C. C., Peschel, C., Oostendorp, R. A. J., & Keller, U. B. (2014) · Oncogene · doi:10.1038/onc.2014.364 · Cited by 15
Cancer stem cells and brain tumors: uprooting the bad seeds
Lee, D. Y., & Gutmann, D. H. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.11.1581 · Cited by 15
Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging
Ju, Z., Zhang, J., Gao, Y., & Cheng, T. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0882-z · Cited by 14
Self-citationLi, Y., Pal, R., Sung, L., Feng, H., Miao, W., Cheng, S., Tian, C., & Cheng, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045212 · Cited by 12
Self-citationp19INK4d: More than Just a Cyclin-Dependent Kinase Inhibitor
Han, X., Kuang, Y., Chen, H., Liu, T., Zhang, J., & Liu, J. (2019) · Current Drug Targets · doi:10.2174/1389450120666190809161901 · Cited by 11
Proliferation of Multiple Cell Types in the Skeletal Muscle Tissue Elicited by Acute p21 Suppression
Biferi, M. G., Nicoletti, C., Falcone, G., Puggioni, E. M. R., Passaro, N., Mazzola, A., Pajalunga, D., Zaccagnini, G., Rizzuto, E., Auricchio, A., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.27 · Cited by 11
The impact of tumor microenvironments on stem cells
Wang, L., Cheng, T., & Zheng, G. (2013) · Translational Cancer Research · doi:10.21037/1675 · Cited by 8
Self-citationOodi, A., Noruzinia, M., Roudkenar, M. H., Nikougoftar, M., Soltanpour, M. S., Khorshidfar, M., & Amirizadeh, N. (2012) · Hematology · doi:10.1179/1607845412y.0000000009 · Cited by 8
Assessing the prognostic value of stemness-related genes in breast cancer patients
Wang, W., Wang, H., Wang, M.-S., Huang, Y., Ma, Y.-Y., Qi, J., Shi, J., & Li, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-73164-3 · Cited by 6
Preleukemic stem cells: leave it or not?
Su, M., Cheng, H., & Cheng, T. (2020) · Blood Science · doi:10.1097/bs9.0000000000000042 · Cited by 6
Self-citationCan precancerous stem cells be risk markers for malignant transformation in the oral mucosa?
Wang, S., Liu, Y., Yu, S., Bai, J., & Hao, C. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00441-0 · Cited by 6
p21/Zbtb18 repress the expression of cKit to regulate the self-renewal of hematopoietic stem cells
Wang, N., Yang, S., Li, Y., Gou, F., Lv, Y., Zhao, X., Wang, Y., Xu, C., Zhou, B., Dong, F., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae022 · Cited by 5
Self-citationEffects of Ethanol on the Regulation of Cell Cycle in Neural Stem Cells
Zawada, W. M., & Das, M. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195183139.003.0012 · Cited by 5
Amirizadeh, N., Oodi, A., Nikougoftar, M., & Soltanpour, M. S. (2013) · Hematology · doi:10.1179/1607845412y.0000000062 · Cited by 4
Czerwonka, A., Lemieszek, M. K., Karpińska, M. M., Matysiak, J., Niewiadomy, A., & Rzeski, W. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2223-8 · Cited by 4
Novel Therapeutic Targets for Hepatocellular Carcinoma Treatment
Chen, Y., & Han, C. (2012) · InTech eBooks · doi:10.5772/28894 · Cited by 2
The Road to Commitment: Lineage Restriction Events in Hematopoiesis
Månsson, R., Zandi, S., Bryder, D., & Sigvardsson, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-85816-6_2 · Cited by 2
Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance
Castven, D., Czauderna, C., & Marquardt, J. U. (2017) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-56197-4_4 · Cited by 2
CANCER BIOLOGY, CANCER MODELS AND SOME NEW APPROACHES TO CARCINOGENESIS
Tan, W., Chen, C. W., & Zhang, L. J. (2008) · Series in Mathematical Biology and Medicine · doi:10.1142/9789812779489_0003 · Cited by 2
THE STEM (CLONOGENIC) CELLS OF CANCER: RETURNING TO THE EARLIER RECEIVED DATA
Чиссов, В. И., Сергеева, Н. С., Sviridova, I. K., & Пелевина, И. И. (2006) · CyberLeninK (CyberLeninka) · Cited by 1
Cell Cycle Control of Stem Cell Fate
Nacusi, L. P., & Sheaff, R. J. (2008) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812775771_0004 · Cited by 1
Franke, K., Vilne, B., da Costa, O. P., Rudelius, M., Peschel, C., Oostendorp, R. A. J., & Keller, U. B. (2015) · Oncotarget · doi:10.18632/oncotarget.5217 · Cited by 1
PKB/Akt kinase localization and role in stemness maintenance in cancer
Jain, M. V. (2016) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-127477 · Cited by 1
Salim, K., Guest, P. C., Skynner, H. A., Bilsland, J., Bonnert, T. P., McAllister, G., & Muñoz-Sanjuán, I. (2007) · Stem Cells and Development · doi:10.1089/scd.2007.16.ft-2 · Cited by 1
GENETIC REGULATION OF HEMATOPOIETIC STEM CELL NUMBERS IN MICE
Liang, Y. (2005) · UKnowledge (University of Kentucky)
Implications of Developmental Switches for Hematopoietic Stem Cell Aging
Nygren, J., & Bryder, D. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_31
Identification of Unique Hematopoietic Stem Cell Properties
Nygren, J. (2005) · Lund University Publications (Lund University)
The role of Diencephalon/Mesencephalon Homeobox 1 (Dmbx1) in Zebrafish Visual System Development
Wong, L. (2013) · TSpace (University of Toronto)
Fator de pluripotência OCT4A e agressividade de meduloblastoma humano
da Silva, P. B. G. (2017) · doi:10.11606/t.41.2017.tde-20032017-161403
Therapeutic targeting of the leukaemic fusion genes
Issa, H. (2019)
Metadata
- Authors
- Cheng, T.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Cheng, Tao
- ORCID
- Cheng, Tao
- Venue
- Oncogene
- Published
- 2004-09-20
- Volume
- 23
- Issue
- 43
- Pages
- 7256-7266
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1991227964
- Cited by
- 117
- References
- 128
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 14 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 4
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Hematology
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL70561, R01HL070561)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK002761, DK 02761)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- cell cycle inhibitors, stem cells, cancer stem cells, hematopoietic stem cells, stem cell differentiation, tissue regeneration, tumor recurrence, carcinogenesis, adult stem cell therapy, tissue homeostasis
- MeSH terms
- Animals, Cell Cycle, Cell Division, Humans, Neoplasm Proteins, Saccharomyces cerevisiae, Stem Cells, Neoplastic Stem Cells, Cyclins, Mice, Knockout, Cell Cycle Proteins, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review